In vivo study demonstrates tumor growth inhibition by combined STING agonism and MEK inhibition in pancreatic cancer models, suggesting therapeutic synergy.
Supplementary Fig. 2 Tumor growth is inhibited by STING agonism and MEK inhibition in vivo.
No takes yet. Share an insight, caveat, or question.
Ghukasyan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: